You are here

  • Home
  • Archive
  • Volume 95, Issue 5
  • Mycoplasma genitalium co-infection with Chlamydia trachomatis and Neisseria gonorrhoeae among asymptomatic patients: the silent wick for macrolide resistance spread

Article Text

Article menu
Download PDFPDF
Miscellaneous
Letter
Mycoplasma genitalium co-infection with Chlamydia trachomatis and Neisseria gonorrhoeae among asymptomatic patients: the silent wick for macrolide resistance spread
  1. Miguel Fernández-Huerta1,
  2. Mateu Espasa1,2
  1. 1 Microbiology Department, Vall d’Hebron University Hospital, Universitat Autònoma de Barcelona, Barcelona, Spain
  2. 2 Drassanes Exprés STI Program, Vall d’Hebron University Hospital, Universitat Autònoma de Barcelona, Barcelona, Spain
  1. Correspondence to Dr Mateu Espasa, Microbiology Department, Vall ďHebron University Hospital, Barcelona 08035, Spain; mespasa{at}vhebron.net, mespasa2002{at}gmail.com

https://doi.org/10.1136/sextrans-2018-053848

Statistics from Altmetric.com

    Request Permissions

    If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

    The screening strategies for Neisseria gonorrhoeae (NG) and Chlamydia trachomatis (CT) implemented among asymptomatic carriers to control STI transmission1 might also result in selection for antibiotic resistance in NG and Mycoplasma genitalium (MG).2 The aim of this study was to determine the MG co-infection rate among asymptomatic people positive for CT and/or NG. A total of 249 users (table 1) attending a STI …

    View Full Text

    Footnotes

    • Handling editor Jackie A Cassell

    • Funding The authors have not declared a specific grant for this research from any funding agency in the public, commercial or not-for-profit sectors.

    • Disclaimer SpeeDx Pty Ltd had no role in study design, data collection and analysis, decision to publish or preparation of the manuscript.

    • Competing interests SpeeDx Pty Ltd supplied all the reagents for molecular testing of M. genitalium. CF-N is a researcher receiving partial salary support from SpeeDx Pty Ltd. MF-H and ME have participated in symposiums organised by SpeeDx Pty Ltd.

    • Patient consent for publication Not required.

    • Provenance and peer review Not commissioned; internally peer reviewed.